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US Hispanics, particularly younger adults in this population, have
a higher prevalence of uncontrolled hypertension than do people
of other racial/ethnic groups. Little is known about the prevalence
and predictors of antihypertensive medication adherence, a major
determinant of hypertension control and cardiovascular disease,
and differences between age groups in this fast-growing popula-
tion.
Methods
The cross-sectional study included 1,043 community-dwelling
Hispanic adults with hypertension living in 3 northern Manhattan
neighborhoods from 2011 through 2012. Age-stratified analyses
assessed the prevalence and predictors of high medication adher-
ence (score  of  8  on the  Morisky Medication Adherence Scale
[MMAS-8]) among younger (<60 y) and older (≥60 y) Hispanic
adults.
Results
Prevalence of high adherence was significantly lower in younger
versus older adults (24.5% vs 34.0%, P = .001). In younger adults,
heavy alcohol consumption, a longer duration of hypertension, and
recent poor physical health were negatively associated with high
adherence, but poor self-rated general health was positively asso-
ciated with high adherence. In older adults, advancing age, higher
education level,  high knowledge of  hypertension control,  and
private insurance or Medicare versus Medicaid were positively as-
sociated with high adherence, whereas recent poor physical health
and health-related activity limitations were negatively associated
with high adherence.
Conclusion
Equitable achievement of national hypertension control goals will
require attention to suboptimal antihypertensive medication adher-
ence found in this study and other samples of US Hispanics, par-
ticularly in younger adults. Age differences in predictors of high
adherence highlight the need to tailor efforts to the life stage of
people with hypertension.
Introduction
Hypertension affects approximately one-third of the US adult pop-
ulation  and is  a  leading risk  factor  for  cardiovascular  disease
(CVD), including heart disease, stroke, and chronic kidney dis-
ease (1). Proper treatment and control of hypertension prevents
first and recurrent CVD, but less than half of people with hyper-
tension in the United States have achieved blood pressure control
(2). Significant hypertension-related disparities have been docu-
mented in Hispanics, the largest and fastest-growing racial/ethnic
group in the United States, leaving this population at risk for dis-
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proportionately negative CVD outcomes. For example, Sorlie et al
reported that only 38% of Hispanics had controlled hypertension,
an important determinant of CVD risk, compared with 56% of
non-Hispanic whites (3).  Furthermore,  only 74% of Hispanics
were aware of their hypertension status compared with 81% of
non-Hispanic whites, and 63% of Hispanics were treated for this
condition compared with 77% of non-Hispanic whites (3).
Antihypertensive medication adherence, defined as the extent of
correspondence between a person’s medication-related behavior
and health care provider recommendations, is an important de-
terminant of hypertension control and improved CVD outcomes
(4,5). On the basis of literature that identifies predictors of adher-
ence in the general population, the World Health Organization
(WHO) Multidimensional Adherence Model classifies predictors
of adherence among 5 multilevel, domains, including health care
system–, patient-, socioeconomic-, therapy-, and condition-related
(4–6). Although Hispanics have lower levels of adherence com-
pared with non-Hispanic whites, little is known about predictors of
adherence in this group (2,7,8). Addressing ethnic disparities in
hypertension control and CVD outcomes requires a better under-
standing of predictors of adherence in these populations.
Although adherence to long-term therapies is known to improve
with  age,  predictors  of  adherence  are  not  necessarily  similar
between  older  and  younger  groups  (5,7,9).  In  general,  young
adults with hypertension have suboptimal hypertension outcomes
(1), which is particularly relevant for Hispanics, who have signi-
ficantly higher rates of hypertension among younger adults than
do non-Hispanic whites of the same age (1). Identifying age-re-
lated differences in predictors of adherence among Hispanics is
important to effectively target factors responsible for documented
age-related and ethnic disparities in hypertension outcomes in the
United States.
To address this gap in the literature, we evaluated the prevalence
and predictors of antihypertensive medication adherence in young-
er and older adults separately, using a large sample of community-
dwelling Hispanic adults with hypertension in New York City. Be-
cause adherence is a complex behavior simultaneously influenced
by multiple individual and environmental factors, we grounded
our assessment in the WHO Multidimensional Adherence Model
framework (4,6). We discuss the implications of our findings for




Data and analytic sample
Data came from the Washington Heights/Inwood Informatics In-
frastructure for Community-Centered Comparative Effectiveness
Research (WICER) project (10,11). Briefly, residents of 3 low-in-
come, primarily immigrant northern Manhattan neighborhoods, re-
cruited through a probability sample of households and snowball
sampling, were asked to participate in an in-person cross-section-
al survey administered by trained, bilingual (Spanish and English)
community health workers from March 2011 through November
2012. Household members aged 18 years or older were eligible to
participate and were offered local grocery store food vouchers for
their time. Informed consent was obtained before survey adminis-
tration, and the study was approved by the Columbia University
Medical Center institutional review board.
This study’s analytic sample comprised respondents who self-
identified as being Hispanic, Latino, or of Spanish origin, repor-
ted a diagnosis of high blood pressure or hypertension by a health
care provider, and were currently taking medication for this condi-
tion (N = 1,043). The sample was categorized as younger (<60 y,
41.1% [n = 429]) and older adults (≥60 y, 58.9%, [n = 614]) to re-
flect the natural distribution of age in this sample (mean age, 61.9
y) and based on age-specific (<60 y, ≥60 y) guidelines for the
management of hypertension in adults (12).
Measures
Antihypertensive medication adherence was assessed using the
self-reported  8-item  Morisky  Medication  Adherence  Scale
(MMAS-8),  which  has  been  validated  against  blood  pressure
levels and shown to be valid in a sample of primarily low-income,
minority patients with hypertension (13). The scale consisted of 8
dichotomous (yes/no, with no coded as 1, indicating higher adher-
ence) or Likert items (normalized to range between 0 and 1, with
higher values indicating higher adherence). Examples of items
were, “Do you ever forget to take your high blood pressure medic-
ation?” and “When you feel like your blood pressure is under con-
trol, do you ever stop taking your medicine?” (13). Recoded items
were summed and ranged from 0 to 8. Internal consistency, meas-
ured using Cronbach α, was good (α =  0.73). The summed score
was dichotomized into high adherence (score of 8) and low or me-
dium adherence (scores of 0 to <8) based on recommended cut
points (13).
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Potential predictors
Demographic characteristics were age in years, sex, and marital
status (divorced/separated/unmarried vs married or cohabiting).
Because 97% of the sample were first-generation immigrants born
outside of the United States, most in the Dominican Republic, ac-
culturation measures included length of stay in the United States
(living in the United States for <10 years vs living in the United
States ≥10 years or US-born) and language of interview (English
vs Spanish). Available survey data on potential correlates were se-
lected and classified according to WHO Multidimensional Adher-
ence Model domains (socioeconomic-, health care system–, pa-
tient-, and condition-related) (4). Therapy-related factors were not
available in the survey and were therefore not included in the as-
sessment.
Socioeconomic or health care system–related factors included edu-
cation level (≤8th grade, some high school [no diploma], high
school diploma/GED, >high school diploma), health insurance
status (any Medicaid including other state- or city-sponsored free
or low-cost plans, private insurance or Medicare only, or unin-
sured),  current employment status (employed vs unemployed),
household composition (lives with >2 people vs lives with ≤2
people or alone), and computer literacy (yes/no), which was meas-
ured as  use of  any social  networking sites  such as   Facebook,
MySpace, or Twitter (10).
Patient-related factors included hypertension control knowledge
and behavioral risk factors. Hypertension control knowledge was
measured using a series of 10 yes/no questions on ways people can
treat or control high blood pressure (eg, taking medication, con-
trolling/losing  weight).  Items  were  summed  into  a  score  that
ranged from 0 to 10 and categorized into high (above median)
versus low (at or below median). Behavioral risk factors included
body mass index (BMI, kg/m2) categories estimated from inter-
viewer-measured height and weight (normal weight, <25.0; over-
weight,  25.0–29.9;  or  obese,  >30.0),  smoking  status  (current
smoker vs never or former smoker), number of alcoholic drinks on
a typical occasion (0, 1 drink/d, ≥2 drinks/d), and the Centers for
Disease Control and Prevention’s (CDC’s) Behavioral Risk Factor
Surveillance  System 30-day physical  activity  measure  (active
defined as moderate or vigorous aerobic physical activity for at
least 10 minutes in past month, dichotomized into active or inact-
ive) (14).
Condition-related factors included duration of hypertension (<5 y,
5 to <10 y, ≥10 y) calculated by subtracting respondents’ age at
survey and age of hypertension diagnosis, and number of comor-
bid conditions (none, 1, or ≥2, based on health care provider’s dia-
gnosis of heart disease, stroke, weak or failing kidneys, cancer, or
diabetes). The 4-item CDC Health-Related Quality of Life (HR-
QOL) scale assessed different HRQOL domains, including self-
rated general health status (fair/poor, good, very good/excellent),
recent (past 30-day) poor physical health (number of physically
unhealthy days due to physical  illness  or  injury),  poor mental
health (number of mentally unhealthy days due to stress, depres-
sion, and problems with emotions), and poor health–related activ-
ity limitation (number of days usual activities [ie, self-care, work,
or recreation] were limited because of poor physical or mental
health) (14). Reported days per month on the latter 3 items were
dichotomized as yes (above median) versus no (at or below medi-
an) due to low observed frequency of the recommended categoriz-
ation of 14 or more days versus fewer than 14 days (15).
Statistical analysis
All analyses were stratified by age group to evaluate the preval-
ence and predictors of high antihypertensive medication adher-
ence separately for younger adults (<60 y) and older adults (≥60
y). Sample characteristics were compared between younger and
older  adults  using frequencies  and means.  Age-group specific
bivariable analyses (χ2 test for categorical variables and standard
2-tailed t tests for continuous variables) assessed the relationship
between each of the potential predictors and high prevalence of
medication adherence. To identify independent predictors of high
adherence, a priori–decided variables (demographics and educa-
tion level) and those associated with high adherence at the P = .10
level in bivariable analyses were included in multivariable Pois-
son regression models with log link function and robust variance,
as has been recommended for binary outcomes with high preval-
ence (16). Adjusted prevalence ratios (APRs) and 95% confid-
ence intervals (CIs) are presented. Multicollinearity was ruled out,
because the variance inflation factors of predictors in linear regres-
sion models were all less than 10. All analyses were conducted us-
ing Stata version 14 (StataCorp LP).
Results
Compared with older adults, younger adults were significantly
more likely to have lived in the United States for less than 10
years, use English as the interview language, be married or cohab-
iting, and have a higher education level (all P < .05); no signific-
ant differences were evident for sex (Table 1). Supplementary Ta-
ble 1 in the Appendix presents a comparison between age groups
for all study variables. In the entire sample, the prevalence of high
adherence was 30.1%. Younger adults had significantly lower pre-
valence of high adherence compared with older adults (24.5% vs
34.0%, P = .001) (Table 1).
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Table 2 presents bivariable and multivariable associations between
study variables and high adherence prevalence.
Demographic, socioeconomic, and health
care–related factors
No demographic variables were significantly associated with high
adherence among younger adults in bivariable analyses. In older
adults, age (mean age [standard deviation] in those with high ad-
herence [69.7 y, (7.2 y)] vs low or medium adherence [68.7 y, (6.9
y)], P = .05) and Spanish (35.9%) versus English (28.1%, P = .08)
language of interview were positively associated high adherence.
Of the socioeconomic/health care–related factors, education level
(>high school, 46.7%; high school diploma/GED, 41.0%; some
high school [no diploma], 40.2%; vs ≤8th grade, 29.2%; P = .01),
insurance status (private or Medicare, 57.1%; uninsured, 41.2%;
vs any Medicaid, 31.4%; P < .001), and employment status (unem-
ployed, 36.3% vs employed, 28.1%; P = .04) were positively asso-
ciated with high adherence. Computer literacy was positively asso-
ciated with high adherence in both younger (41.7% vs 22.8% not
computer literate; P = .01) and older (57.6% vs 32.2% not com-
puter literate; P = .003) adults.
In younger adults,  none of the demographic or socioeconomic
status or health care–related factors remained significant in mul-
tivariable analyses.  In older adults,  age (APR = 1.02; 95% CI,
1.00–1.04; P = .02),  education (>high school diploma vs ≤8th
grade, APR = 1.51; 95% CI, 1.06–2.14; P = .02) and insurance
status (private or Medicare vs any Medicaid, APR = 1.67; 95% CI,
1.18–2.38; P = .004) remained positively related to high adher-
ence.
Patient-related factors
In bivariable analyses, only in younger adults were typical alcohol
consumption (1 drink/d, 23.1%; ≥2 drinks/d, 16.4%; vs nondrink-
ers, 27.5%; P = .08) and smoking status (current smoker, 46.7% vs
never/former smoker, 22.7%; P = .003) related to high adherence.
Among older adults, only blood pressure control knowledge score
(high score, 46.3% vs low score, 24.4%; P < .001) and physical
activity (active, 54.1% vs inactive, 32.6%; P = .007) were posit-
ively associated with high adherence.
In multivariable analyses, alcohol consumption remained negat-
ively associated with high adherence (≥2 drinks/d vs nondrinker,
APR = 0.58; 95% CI, 0.35–0.95; P = .03) in younger adults. In
older adults, only hypertension control knowledge positively pre-
dicted  high  adherence  (high  vs  low,  APR  =  1.70;  95%  CI,
1.30–2.22; P < .001).
Condition-related factors
In bivariable analyses, in younger adults duration of hypertension
was negatively associated with high adherence (5 to <10 y, 26.7%;
≥10 years,  19.9%; vs  <5 y,  34.4%; P = .03).  Among HRQOL
measures, recent poor physical health was negatively associated
with high adherence in younger (yes, 14.1% vs no, 31.9%; P <
.001) and older adults (yes, 20.3% vs no, 42.7%; P < .001). Simil-
arly, recent poor mental health was negatively related to adher-
ence in younger adults (yes, 16.0% vs no, 26.6%; P = .06) and
older adults (yes, 17.0% vs no, 38.5%, P < .001). Poor health–re-
lated activity limitation was negatively related to high adherence
only in older adults (yes, 12.8% vs no, 38.5%; P < .001). Con-
versely, in younger adults, those with poorer self-rated general
health  had  a  higher  prevalence  of  high  adherence  (fair/poor,
38.6%; good, 31.3%; vs very good/excellent, 17.4%; P < .001).
In multivariable analyses, duration of hypertension (≥10 y vs <5 y,
APR = 0.54; 95% CI, 0.34–0.84; P = .006) remained negatively
related to adherence in younger adults. Among HRQOL domains,
recent poor physical health remained negatively associated with
high adherence in both younger (APR = 0.53; 95% CI, 0.33–0.87;
P = .01) and older (APR = 0.51; 95% CI, 0.35–0.74; P < .001)
adults. Poor health–related activity limitation (APR = 0.35; 95%
CI, 0.17–0.70; P < .001) remained negatively related to high ad-
herence in older adults. In younger adults, those with poor or fair
self-rated health versus very good or excellent self-rated health
had a higher prevalence of high adherence (APR = 2.37; 95% CI,
1.54–3.63; P < .001).
Discussion
We found low levels of high adherence to antihypertensive medic-
ation in a sample of urban community-dwelling Hispanics. Find-
ing were consistent with those in previous research (2,7); adher-
ence estimates from our sample (less than a quarter of younger
adults and approximately one-third of older adults) were substan-
tially lower than estimates from previous studies in non-Hispanic
community-dwelling adults with hypertension (ranging from 36%
to 58% in studies using the MMAS-8) (17–19). These disparities
in adherence may in part explain the documented lower rates of
hypertension control in US Hispanics (3). Healthy People 2020
sets national population-level hypertension and CVD goals, in-
cluding targets for adherence to prescribed medications among
adults with hypertension (20). Our results suggest that equitable
achievement of these national goals will require particular atten-
tion to suboptimal antihypertensive medication adherence found in
this  study and other  samples  of  US Hispanics,  particularly  in
younger adults.
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This study used the WHO Multidimensional Adherence Model to
systematically assess predictors of antihypertensive medication ad-
herence by age (4). Our finding were consistent with findings from
previous studies, in which younger adults were significantly less
likely to  have high adherence than were older  adults  (5,7,18).
Within age group–specific analyses, however, advancing age pre-
dicted adherence only among older adults. Conversely, a longer
duration of hypertension, independent of age, predicted lower ad-
herence only among younger adults, a finding consistent with lon-
gitudinal findings that antihypertensive therapy persistence (con-
tinued adherence with recommended therapy) declines over time
to a greater degree in newly diagnosed younger adults  than in
older adults (21). This finding may indicate the role of declining
motivation  to  persistently  adhere  to  medication  over  time  in
younger people with hypertension, potentially given the asympto-
matic nature of hypertension and the later age of manifestation of
chronic CVD. Taken together with our findings, this finding sug-
gests that duration of illness may be a stronger predictor of adher-
ence in younger adults, whereas advancing age may be more pre-
dictive of adherence in older adults, perhaps coinciding with bet-
ter familiarity and acceptance of aging-related processes.
Socioeconomic and health care–related variables were predictive
of high adherence only in older adults. A higher education level
predicted adherence only in older adults. Although previous re-
search is inconsistent regarding age-related variation in the associ-
ation between education and health, our results support the cumu-
lative advantage hypothesis, which suggests that educational dis-
parities in health are larger in older individuals (22,23). This may
indicate that the cognitive, psychosocial, and material resources
afforded by better education are deployed for better adherence
more effectively by older than by younger adults (23). Our find-
ings were also consistent with findings in prior research with older
adults, in which having private insurance or Medicare only was as-
sociated with better adherence than having any Medicaid (24).
Conversely,  insurance  status  was  not  related  to  adherence  in
younger adults. Research has shown significantly higher levels of
cost-related  nonadherence  to  antihypertensive  medications  in
younger adults, irrespective of coverage — possibly because of
competing expenditure priorities during this life stage (25). This
finding may mean that treatment cost burden, a factor we did not
assess, independent of insurance status may be a more relevant
barrier to adherence in this age group and especially in our low-in-
come sample. Future efforts must consider not just access barriers
but also higher out-of-pocket medication expenses, a main contrib-
utor to cost-related nonadherence in older and especially younger
adults (25,26).
In terms of patient factors, our findings were consistent with find-
ings of prior literature; increasing levels of alcohol consumption
negatively predicted high adherence in younger adults but know-
ledge of blood pressure control positively predicted high adher-
ence in older adults (27). Interventions targeting alcohol behavi-
ors in younger adults must consider potential mechanisms, includ-
ing alcohol’s role in promoting forgetfulness, willful nonadher-
ence to avoid drug interactions, or maladaptive coping in young
people facing serious chronic conditions (27). The positive rela-
tionship between blood pressure control knowledge and adher-
ence in older adults alone may highlight the importance of superi-
or knowledge and cognition in aging populations (4,6). However,
education-based efforts at improving patient knowledge must be
sustained for long periods while also combining them with other
evidence-based strategies (8).
Finally, among condition-related factors, in younger adults, incon-
sistencies were observed in the relationship between domains of
HRQOL and high adherence. Consistent with findings of some
other studies, our finding was that those with better self-rated gen-
eral health had a lower prevalence of adherence, suggesting that in
younger adults, self-appraisal of general health as “excellent” or
“very good” may trigger nonadherence, possibly given that many
in this age group have not developed physical CVD symptoms yet
(28,29). Conversely, recent poor physical health also predicted a
lower prevalence of high adherence, suggesting that physical dis-
ease symptoms may be associated with reduced adherence. There-
fore, different domains of HRQOL may have distinct influences
on adherence in younger adults, and future research must expli-
citly understand the mechanisms by which specific aspects of HR-
QOL influence  adherence  in  this  age  group  (29,30).  In  older
adults, both poor physical health and poor health–related activity
limitation were associated with lower prevalence of adherence, in-
dicating that aging-related physical health symptoms and associ-
ated disabilities may be important barriers to adherence in older
populations. On the other hand, in both younger and older adults,
recent poor mental HRQOL was significantly related to high ad-
herence in bivariable but not in adjusted analyses. Although prior
research has been largely inconsistent regarding the role of mental
health HRQOL measures in predicting adherence (29,30), clinical
measures of mental health (eg, depression, depressive symptoms)
have consistently been documented as predictors of adherence (6),
including among Hispanics (28). Future research must delineate
the  relevance  of  specific  measures  of  mental  health  (HRQOL
measures vs clinical measures) in relation to adherence.
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This study addresses important gaps in the literature. Specifically,
our systematic assessment identified several previously unevalu-
ated factors associated with antihypertensive medication adher-
ence in an understudied population using a large sample of His-
panics and validated measures (6,8). However, our study has limit-
ations. The cross-sectional nature of this study precludes causal
claims regarding the relationship between the identified predictors
and adherence. Longitudinal studies of adherence among recently
diagnosed individuals would be useful in confirming our results.
Also, there is potential for response bias because of self-reported
data. However, this risk is minimal, given that the survey used
widely validated measures and standardized protocols for adminis-
tration. The study population comprised mostly first-generation
immigrants born in the Dominican Republic residing in northern
Manhattan, limiting generalizations to other US Hispanic sub-
groups (3).  Conducting similar  studies  in  other  Hispanic  sub-
groups  would  be  fruitful.  Finally,  the  broad categorization  of
younger adults as those younger than 60 years may mask further
age differences in predictors of adherence within this age group.
However, sensitivity analyses found no differences in patterns of
predictors across even younger ages (<50 y and 50–59 y) (Ap-
pendix, Supplementary Table 2).
Our finding of suboptimal antihypertensive medication adherence
should be considered in conjunction with evidence of lower levels
of hypertension awareness, diagnosis, and treatment among US
Hispanics (3). This evidence suggests that addressing adherence,
while critical, can form only part of the efforts to tackle ethnic dis-
parities in hypertension control. Younger adults were less likely to
have high adherence, and evidence of declining adherence with
longer duration in this group indicates the need to target persistent
adherence in these individuals  to  ensure hypertension control.
Younger and older people with hypertension shared few predict-
ors of adherence. Interventions to improve adherence targeting so-
cioeconomic and health care resources,  aging-related physical
health and activity limitations, and educational efforts to improve
knowledge may be better suited for older Hispanics with hyperten-
sion, whereas efforts targeting risky behaviors and specific do-
mains of HRQOL may be more relevant among younger Hispan-
ics with hypertension. At the very least, evidence of these age-re-
lated  differences  highlights  the  importance  of  developing  ap-
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Tables
Table 1. Selected Sociodemographic Characteristics and High Antihypertensive Medication Adherence Prevalence Among Hispanic Adults With Hypertension by Age
Group, WICER Survey, New York City, 2011–2012
Characteristic Younger Adults (<60 y) Older Adults (≥60 y) P Valuea
Total, % (n) 41.1 (429) 58.9 (614) —
High medication adherence, % (n)b 24.5 (105) 34.0 (209) .001
Mean age, y (SD) 51.7 (6.9) 69.1 (7.0) <.001
Sex, % (n)
Male 26.3 (113) 23.6 (145)
.32
Female 73.7 (316) 76.4 (469)
Immigration status, % (n)
Living in United States for <10 y 13.1 (54) 7.9 (46)
.007
Living in United States ≥10 y or US-born 86.9 (357) 92.1 (537)
Language of interview, % (n)
English 31.2 (134) 23.8 (146)
.007
Spanish 68.8 (295) 76.2 (468)
Marital status, % (n)
Divorced/separated/unmarried 59.1 (251) 66.9 (409)
.009
Married or cohabiting 40.9 (174) 33.1 (202)
Education level, % (n)
≤8th grade 34.7 (146) 66.2 (397)
<.001
Some high school (no diploma) 21.9 (92) 13.7 (82)
High school diploma/GED 20.0 (84) 10.2 (61)
>High school diploma 23.5 (99) 10.0 (60)
Abbreviations: —, not applicable; GED, general educational development test; SD, standard deviation; WICER, Washington Heights/Inwood Informatics Infrastruc-
ture for Community-Centered Comparative Effectiveness Research.
a P value determined by χ2 test for categorical variables and standard 2-tailed t test for continuous variables.
b High adherence (score of 8) versus low adherence (scores of 0 to <8) on 8-item Morisky Medication Adherence Scale (MMAS-8).
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Table 2. Age-Specific Bivariable and Multivariable Predictors of High Antihypertensive Medication Adherencea Prevalence Among Hispanic Adults With Hyperten-
sion, WICER Survey, New York City, 2011–2012
Characteristic
Younger Adults (<60 y) Older Adults (≥60 y)
Value P Valueb APRc (95% CI) P Value Value P Valueb APRc (95% CI) P Value
Demographics
Mean age, y (SD) 52.0 (6.8) vs
51.6 (6.9)
.65 1.02 (0.99–1.06) .18 69.7 (7.2) vs
68.7 (6.9)










Female 25.3 0.93 (0.64–1.36) 33.3 0.92 (0.71–1.21)
Immigration status, %







.16Living in United States ≥10 y or US-
born
24.4 0.87 (0.54–1.41) 33.7 0.75 (0.50–1.12)
























1 [Reference] — 29.2
.01
1 [Reference] —
Some high school (no diploma) 18.5 0.67 (0.38–1.18) .17 40.2 1.33 (0.92–1.92) .13
High school diploma/GED 28.6 1.01 (0.61–1.68) .96 41.0 1.18 (0.79–1.77) .41







Private or Medicare only 22.0 — — 57.1 1.67 (1.18–2.38) .004
Uninsured 37.8 — — 41.2 1.78 (0.86–3.70) .12







Unemployed 25.5 — — 36.3 0.93 (0.69–1.25)
Abbreviations: —, not applicable; APR, adjusted prevalence ratio; CI, confidence interval; GED, general educational development test; SD, standard deviation;
WICER, Washington Heights/Inwood Informatics Infrastructure for Community-Centered Comparative Effectiveness Research.
a High adherence (score of 8) and low or medium (scores of 0 to <8) on 8-item Morisky Medication Adherence Scale (MMAS-8). Only demographics, education
level, and variables associated with high adherence at the P = .10 level in bivariate analyses were included in multivariate analyses.
b P value determined by using χ2 test for categorical variables and standard 2-tailed t tests for continuous variables.
c Adjusted for all demographics, education level, and variables associated with high adherence at the P = .10 level in bivariable analyses. APRs, 95% CIs, and P val-
ues based on Poisson regression models with log link and robust variance.
d Including other state- or city-sponsored free or low-cost insurance.
e Defined as use of any social networking sites such as Facebook, MySpace, or Twitter.
f Summed score based on following yes/no items: controlling or losing weight, reducing stress, eating healthfully, reducing salt intake, exercising, reducing alcohol
use, stopping smoking, taking medication, other dietary changes, visiting a medical professional.
g Assessed by using the Centers for Disease Control and Prevention’s Health-Related Quality of Life scale (14).
(continued on next page)
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(continued)
Table 2. Age-Specific Bivariable and Multivariable Predictors of High Antihypertensive Medication Adherencea Prevalence Among Hispanic Adults With Hyperten-
sion, WICER Survey, New York City, 2011–2012
Characteristic
Younger Adults (<60 y) Older Adults (≥60 y)
Value P Valueb APRc (95% CI) P Value Value P Valueb APRc (95% CI) P Value
Household composition, %















Yes 41.7 1.64 (0.97–2.78) 57.6 1.27 (0.83–1.95)
Patient-Related Factors







High 25.8 — — 46.3 1.70 (1.30–2.22)
Weight status (body mass index, kg/m2), %





Overweight (25.0–29.9) 24.5 — — 35.3 — —
Obese (>30.0) 26.1 — — 31.2 — —
Alcohol consumption on typical occasion, %
Nondrinker 27.5
.08
1 [Reference] — 33.1
.84
— —
1 drink/d 23.1 0.78 (0.46–1.30) .34 34.9 — —

















Active 31.5 — — 54.1 1.40 (0.99–1.98)
Condition-Related Factors
Duration with hypertension, y, %
<5 34.4
.03
1 [Reference] — 30.3
.60
— —
5 to <10 26.7 0.63 (0.39–1.02) .06 37.8 — —
Abbreviations: —, not applicable; APR, adjusted prevalence ratio; CI, confidence interval; GED, general educational development test; SD, standard deviation;
WICER, Washington Heights/Inwood Informatics Infrastructure for Community-Centered Comparative Effectiveness Research.
a High adherence (score of 8) and low or medium (scores of 0 to <8) on 8-item Morisky Medication Adherence Scale (MMAS-8). Only demographics, education
level, and variables associated with high adherence at the P = .10 level in bivariate analyses were included in multivariate analyses.
b P value determined by using χ2 test for categorical variables and standard 2-tailed t tests for continuous variables.
c Adjusted for all demographics, education level, and variables associated with high adherence at the P = .10 level in bivariable analyses. APRs, 95% CIs, and P val-
ues based on Poisson regression models with log link and robust variance.
d Including other state- or city-sponsored free or low-cost insurance.
e Defined as use of any social networking sites such as Facebook, MySpace, or Twitter.
f Summed score based on following yes/no items: controlling or losing weight, reducing stress, eating healthfully, reducing salt intake, exercising, reducing alcohol
use, stopping smoking, taking medication, other dietary changes, visiting a medical professional.
g Assessed by using the Centers for Disease Control and Prevention’s Health-Related Quality of Life scale (14).
(continued on next page)
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(continued)
Table 2. Age-Specific Bivariable and Multivariable Predictors of High Antihypertensive Medication Adherencea Prevalence Among Hispanic Adults With Hyperten-
sion, WICER Survey, New York City, 2011–2012
Characteristic
Younger Adults (<60 y) Older Adults (≥60 y)
Value P Valueb APRc (95% CI) P Value Value P Valueb APRc (95% CI) P Value




1 [Reference] — 35.4
.64
— —
1 17.7 0.69 (0.43–1.11) .13 31.8 — —
≥2 28.6 0.87 (0.47–1.63) .67 31.4 — —









Yes 14.1 0.53 (0.33–0.87) 20.3 0.51 (0.35–0.74)









Yes 16.0 0.63 (0.32–1.24) 17.0 0.86 (0.46–1.59)











1 [Reference] — 31.3
.17
— —
Good 31.3 1.45 (0.92–2.28) .11 37.4 — —
Fair/poor 38.6 2.37 (1.54–3.63) <.001 35.8 — —
Abbreviations: —, not applicable; APR, adjusted prevalence ratio; CI, confidence interval; GED, general educational development test; SD, standard deviation;
WICER, Washington Heights/Inwood Informatics Infrastructure for Community-Centered Comparative Effectiveness Research.
a High adherence (score of 8) and low or medium (scores of 0 to <8) on 8-item Morisky Medication Adherence Scale (MMAS-8). Only demographics, education
level, and variables associated with high adherence at the P = .10 level in bivariate analyses were included in multivariate analyses.
b P value determined by using χ2 test for categorical variables and standard 2-tailed t tests for continuous variables.
c Adjusted for all demographics, education level, and variables associated with high adherence at the P = .10 level in bivariable analyses. APRs, 95% CIs, and P val-
ues based on Poisson regression models with log link and robust variance.
d Including other state- or city-sponsored free or low-cost insurance.
e Defined as use of any social networking sites such as Facebook, MySpace, or Twitter.
f Summed score based on following yes/no items: controlling or losing weight, reducing stress, eating healthfully, reducing salt intake, exercising, reducing alcohol
use, stopping smoking, taking medication, other dietary changes, visiting a medical professional.
g Assessed by using the Centers for Disease Control and Prevention’s Health-Related Quality of Life scale (14).
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Appendix. Supplementary Tables
This appendix is available for download as a Microsoft Word document at
https://www.cdc.gov/pcd/issues/2017/docs/16_0512Appendix.docx [DOCX – 22 KB].
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